Mallinckrodt Pharmaceuticals
Mallinckrodt, which has its headquarters in Mulhuddart, Dublin 15 but operates from its location in Missouri in the US, is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Mallinckrodt was spun-off by Covidien in 2013.
Financial Data
-
28th Dec 18 Source: CRO
- €2.9 billion turnover
-
-€3.6 billion
profit - 3,517 employees
-
29th Dec 17 Source: Company
- €3.3 billion turnover
-
-€135 million
profit - 4,089 employees
- 2 more years available »
Ranking
By Turnover
(€2.9 billion)- 36th in Top Companies
By Employees
(3,517)- 64th in Top Companies
- 3,517
- €2.9 billion
Employees
- David Keenan Vice President}
Latest News
- May 25 Three candidates to contest presidency of ICSA
- May 25 GDPR one year on: No fines but considerable amounts of dread
- May 25 Singapore investor to acquire Dublin docks office scheme for €240m
- May 25 Microsoft moves $52.8bn of assets and its Asian trading operation to Ireland
- May 25 Investors eye 300 apartments at Citywest Shopping Centre